Latest News about Obesity
Recent news which mentions Obesity
The weight-loss drug boom has become one of the internet's biggest scams
December 08, 2024
From CNBC.com News
From Benzinga
Amgen Reveals Data From Closely Watched Monthly Obesity Drug, With Weight Loss Of Up To 20% At One Year And No Plateau
November 26, 2024
From Benzinga
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
October 24, 2024
From CNBC.com News
Ozempic is driving up the cost of your health care, whether you can get your hands on it or not
October 11, 2024
From CNBC.com News
From Benzinga
Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound caught up in East Coast trade shutdown
October 01, 2024
From CNBC.com News
Corbus Pharma (CRBP) Stock Drops 60% After Novo Nordisk's Cannabinoid-Based Weight Loss Drug Trial Disappoints
September 20, 2024
From Benzinga
CNBC Daily Open: A 'crazy' summer
August 21, 2024
From CNBC.com News
CNBC Daily Open: 'Crazy' summer
August 20, 2024
From CNBC.com News
CNBC Daily Open: Rising geopolitical risk
July 18, 2024
From CNBC.com News
CNBC Daily Open: Rising geopolitical risk
July 17, 2024
From CNBC.com News
Novo Nordisk's 'Miracle' Weight Loss Drug Ozempic Linked To 48% Lower Risk Of Dementia, Study Finds
July 12, 2024
From Benzinga
From Benzinga
From PRLog
Chinese Generic Ozempic, Wegovy Versions Could Put Novo Nordisk At The Risk Of Stiff Competition In Key Market
June 05, 2024
From Benzinga
From CNBC.com News
Weight-Loss Drug Forecasts Skyrocket To $150B As Novo Nordisk, Eli Lilly Ramp Up Supply
May 29, 2024
From Benzinga
This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan
May 21, 2024
From Benzinga
Friday File: NVIDIA by the Fingernails, Gold (and other shiny things), Energy Storage and more…
March 22, 2024
Tickers
GOLD
From Stock Gumshoe
From Benzinga
Weight Watchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit
March 14, 2024
From CNBC.com News
From CNBC.com News
US Health Agency Reviews Novo Nordisk's Wegovy For Potential Use In Treating Heart Disease Patients With Obesity
March 12, 2024
From Benzinga
Ozempic Maker Novo Nordisk To Introduce Obesity Drug Wegovy In Japan, Acknowledging Country's Rising Weight Issue
March 07, 2024
From Benzinga
WeightWatchers Stock Falls After Q4 Results, Oprah Winfrey Exits
February 28, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.